期刊文献+

护骨素与骨质疏松研究进展 被引量:2

暂未订购
导出
出处 《河北医科大学学报》 CAS 2007年第1期70-72,共3页 Journal of Hebei Medical University
基金 河北省自然科学基金资助项目(303496) 河北省高等学校博士科研资助基金项目(B2004203) 河北省卫生厅基金(3166)
  • 相关文献

参考文献20

  • 1Eghbali Fatourechi G,Khosla S,Sanyal A,et al.Role of Rank Ligand in mediating increased bone resorption in early postmenopausal women[J].J Clin invest,2003,111 (8):1120-1122.
  • 2Vidal K,van den Broek P,Lorget F,et al,Osteoprotegerin in Human Milk:A potential role in the regulation of bone metabolism and immune development[J].Pediatr Res,2004,55(6):1001-1008.
  • 3Hong JS,Santolaya-Forgas J,Romerao R,et al.Maternal plasma osteoprotegerin concentration in normal pregnancy[J].Am J Obstet Gynecol,2005,193(3 Pt 2):1011-1015.
  • 4Aubin JE Bonnelye.Osteoprotegerin and its ligand:a new paradigm for regulation of osteoclastogenesis and bone resorption[J].Ostoporos Int,2000,11 (11):905-913.
  • 5Koshihara Y,Hoshi K,Okawara R,et al.Vitamin K stimulates osteoblastogenesis and inhibits osteoblastogenesis in human bone marrow cell culture[J].J Endocrinol,2003,176(3):339-348.
  • 6Hollowday WR,Collier FM,Aitken CJ,et al.Leptin inhibits osteoclast generation[J].J Bone Miner Res,2002,17 (2):200-209.
  • 7Golledge J,McCann M,Mangan S,et al.Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis[J].Stroke,2004,35 (7):1636-1341.
  • 8Anca Irinel Catrina,Erikaf Klint,Sofia Ernestam,et al.Antitumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis[J].Arthritis & Rheumatism,2006,54 (1):76-81.
  • 9Yamada N,Tsujimura T,Ueda H.et al.Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophages colony-stimulating factor[J].Cytokine,2005,31(4):288-297.
  • 10Ohazama A,Courtney JM,Sharpe PT.Opg,Rank,and Rankl in tooth development:Co-ordination of odontogenesis and osteogenesis[J].J Dent Res,2004,83 (3):241-244.

二级参考文献9

  • 1Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:309-319.
  • 2Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun, 1999, 256:449-455.
  • 3Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem, 1998, 273:14363-14367.
  • 4Sumbrook J. Molecular cloning laboratory manual. 2nd ed. New York: Cold Spring Harbor laboratory Press, 1989. 345-897.
  • 5Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev, 1994, 15: 275-300.
  • 6Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology, 1999, 140:4367-4370.
  • 7Atkins G, Haynes DR, Graves SE, et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res, 2000, 15: 640-649.
  • 8Murakami T, Yamamoto M, Ono K, et al. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun, 1998, 252:747-752.
  • 9Sibonga JD, Dobnig H, Harden RM, et al. Effect of the high-affinity estrogen receptor ligand ICI182,780 on the rat tibia. Endocrinology, 1998,139:3736-3742.

共引文献12

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部